Skip to main content
Top
Published in: Current Treatment Options in Neurology 11/2017

01-11-2017 | Neurologic Ophthalmology and Otology (RK Shin and DR Gold, Section Editors)

Current Treatment Options: Vestibular Migraine

Authors: Clinton G. Lauritsen, DO, Michael J. Marmura, MD

Published in: Current Treatment Options in Neurology | Issue 11/2017

Login to get access

Opinion statement

Vestibular migraine (VM) is a disorder with a spectrum of clinical presentations and among the most common causes of chronic vestibular symptoms. Some present with attacks before or during typical migraine, but many others have fluctuating or daily symptoms. While the symptoms and pathogenesis of vestibular migraine may have elements of both central and peripheral disorders, hearing loss should be absent. VM typically worsens with activity and head movements in general, and encompasses symptoms of vertigo, disequilibrium, or imbalance. While it is possible to confuse other disorders such as Meniere’s disease with migraine, it is worth making the diagnosis of vestibular migraine on clinical grounds after ruling out other possible causes. For acute attack treatment, migraine-specific medications such as triptans may be effective. In patients with frequent or disabling attacks, preventive treatment is essential. Vestibular rehabilitation may be helpful as well as medications used for migraine prevention such as including propranolol, venlafaxine, topiramate, and amitriptyline. For refractory patients, use of acetazolamide or lamotrigine may be reasonable.
Literature
1.
go back to reference Stovner L, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.CrossRefPubMed Stovner L, et al. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia. 2007;27(3):193–210.CrossRefPubMed
2.
go back to reference Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–15.CrossRefPubMed Woldeamanuel YW, Cowan RP. Migraine affects 1 in 10 people worldwide featuring recent rise: a systematic review and meta-analysis of community-based studies involving 6 million participants. J Neurol Sci. 2017;372:307–15.CrossRefPubMed
3.
go back to reference • Vukovic V, et al. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache. 2007;47(10):1427–35. This article is one of few population studies assessing prevalence of migrainous vertigo.CrossRefPubMed • Vukovic V, et al. Prevalence of vertigo, dizziness, and migrainous vertigo in patients with migraine. Headache. 2007;47(10):1427–35. This article is one of few population studies assessing prevalence of migrainous vertigo.CrossRefPubMed
4.
go back to reference •• Neuhauser HK, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67(6):1028–33. This article is the largest population study assessing prevalence of migrainous vertigo.CrossRefPubMed •• Neuhauser HK, et al. Migrainous vertigo: prevalence and impact on quality of life. Neurology. 2006;67(6):1028–33. This article is the largest population study assessing prevalence of migrainous vertigo.CrossRefPubMed
6.
go back to reference Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the international classification of vestibular disorders. Neurol Clin. 2015;33(3):541–50. viiCrossRefPubMed Bisdorff AR, Staab JP, Newman-Toker DE. Overview of the international classification of vestibular disorders. Neurol Clin. 2015;33(3):541–50. viiCrossRefPubMed
7.
go back to reference Cal R, Bahmad F Jr. Migraine associated with auditory-vestibular dysfunction. Braz J Otorhinolaryngol. 2008;74(4):606–12.CrossRefPubMed Cal R, Bahmad F Jr. Migraine associated with auditory-vestibular dysfunction. Braz J Otorhinolaryngol. 2008;74(4):606–12.CrossRefPubMed
9.
go back to reference •• Headache Classification Committee of the International Headache, S. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This publication defines the current standard for diagnosis of vestibular migraine.CrossRef •• Headache Classification Committee of the International Headache, S. The international classification of headache disorders, 3rd edition (beta version). Cephalalgia. 2013;33(9):629–808. This publication defines the current standard for diagnosis of vestibular migraine.CrossRef
10.
go back to reference •• Neuhauser H, et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436–41. This article features population data analyzing features of migrainous vertigo.CrossRefPubMed •• Neuhauser H, et al. The interrelations of migraine, vertigo, and migrainous vertigo. Neurology. 2001;56(4):436–41. This article features population data analyzing features of migrainous vertigo.CrossRefPubMed
11.
go back to reference Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246(10):883–92.CrossRefPubMed Dieterich M, Brandt T. Episodic vertigo related to migraine (90 cases): vestibular migraine? J Neurol. 1999;246(10):883–92.CrossRefPubMed
12.
go back to reference Chen J, et al. Clinical characteristics of 100 vestibular migraine cases. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30(5):399–401.PubMed Chen J, et al. Clinical characteristics of 100 vestibular migraine cases. Lin Chung Er Bi Yan Hou Tou Jing Wai Ke Za Zhi. 2016;30(5):399–401.PubMed
13.
go back to reference Van Ombergen A, et al. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol. 2015;36(1):133–8.PubMed Van Ombergen A, et al. Vestibular migraine in an otolaryngology clinic: prevalence, associated symptoms, and prophylactic medication effectiveness. Otol Neurotol. 2015;36(1):133–8.PubMed
14.
go back to reference Langhagen T, et al. Vestibular migraine in children and adolescents: clinical findings and laboratory tests. Front Neurol. 2014;5:292.PubMed Langhagen T, et al. Vestibular migraine in children and adolescents: clinical findings and laboratory tests. Front Neurol. 2014;5:292.PubMed
15.
go back to reference Qiu F, et al. An analysis of clinical features of 226 vestibular migraine patients. Zhonghua Nei Ke Za Zhi. 2014;53(12):961–3.PubMed Qiu F, et al. An analysis of clinical features of 226 vestibular migraine patients. Zhonghua Nei Ke Za Zhi. 2014;53(12):961–3.PubMed
16.
go back to reference Goto F, Tsutsumi T, Ogawa K. The clinical features of migraine-associated vertigo. Nihon Jibiinkoka Gakkai Kaiho. 2013;116(8):953–9.CrossRefPubMed Goto F, Tsutsumi T, Ogawa K. The clinical features of migraine-associated vertigo. Nihon Jibiinkoka Gakkai Kaiho. 2013;116(8):953–9.CrossRefPubMed
17.
go back to reference Martinez E, et al. Clinical characteristics of vestibular migraine: considerations in a series of 41 patients. Rev Neurol. 2017;64(1):1–6.PubMed Martinez E, et al. Clinical characteristics of vestibular migraine: considerations in a series of 41 patients. Rev Neurol. 2017;64(1):1–6.PubMed
18.
go back to reference Neff BA, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Meniere’s disease, vestibular migraine, and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–44.CrossRefPubMed Neff BA, et al. Auditory and vestibular symptoms and chronic subjective dizziness in patients with Meniere’s disease, vestibular migraine, and Meniere’s disease with concomitant vestibular migraine. Otol Neurotol. 2012;33(7):1235–44.CrossRefPubMed
19.
go back to reference Kattah JC, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504–10.CrossRefPubMedPubMedCentral Kattah JC, et al. HINTS to diagnose stroke in the acute vestibular syndrome: three-step bedside oculomotor examination more sensitive than early MRI diffusion-weighted imaging. Stroke. 2009;40(11):3504–10.CrossRefPubMedPubMedCentral
20.
21.
22.
go back to reference Minor LB, et al. Symptoms and signs in superior canal dehiscence syndrome. Ann N Y Acad Sci. 2001;942:259–73.CrossRefPubMed Minor LB, et al. Symptoms and signs in superior canal dehiscence syndrome. Ann N Y Acad Sci. 2001;942:259–73.CrossRefPubMed
23.
go back to reference Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1–9. discussion 9-10PubMed Matthies C, Samii M. Management of 1000 vestibular schwannomas (acoustic neuromas): clinical presentation. Neurosurgery. 1997;40(1):1–9. discussion 9-10PubMed
24.
go back to reference Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand. 1995;91(1):43–8.CrossRefPubMed Norrving B, Magnusson M, Holtas S. Isolated acute vertigo in the elderly; vestibular or vascular disease? Acta Neurol Scand. 1995;91(1):43–8.CrossRefPubMed
25.
go back to reference Bulsara KR, Velez DA, Villavicencio A. Rotational vertebral artery insufficiency resulting from cervical spondylosis: case report and review of the literature. Surg Neurol. 2006;65(6):625–7.CrossRefPubMed Bulsara KR, Velez DA, Villavicencio A. Rotational vertebral artery insufficiency resulting from cervical spondylosis: case report and review of the literature. Surg Neurol. 2006;65(6):625–7.CrossRefPubMed
26.
27.
go back to reference Vongvaivanich K, et al. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2015;35(10):894–911.CrossRefPubMed Vongvaivanich K, et al. Late-life migraine accompaniments: a narrative review. Cephalalgia. 2015;35(10):894–911.CrossRefPubMed
28.
go back to reference • Sohn JH. Recent advances in the understanding of vestibular migraine. Behav Neurol. 2016;2016:1801845. This article features recent evidence for pathophysiological mechanisms in vestibular migraine.CrossRefPubMedPubMedCentral • Sohn JH. Recent advances in the understanding of vestibular migraine. Behav Neurol. 2016;2016:1801845. This article features recent evidence for pathophysiological mechanisms in vestibular migraine.CrossRefPubMedPubMedCentral
29.
go back to reference Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706–15.CrossRefPubMed Furman JM, Marcus DA, Balaban CD. Vestibular migraine: clinical aspects and pathophysiology. Lancet Neurol. 2013;12(7):706–15.CrossRefPubMed
30.
go back to reference Balaban CD, Jacob RG, Furman JM. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 2011;11(3):379–94.CrossRefPubMedPubMedCentral Balaban CD, Jacob RG, Furman JM. Neurologic bases for comorbidity of balance disorders, anxiety disorders and migraine: neurotherapeutic implications. Expert Rev Neurother. 2011;11(3):379–94.CrossRefPubMedPubMedCentral
31.
go back to reference Vass Z, et al. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience. 1998;84(2):559–67.CrossRefPubMed Vass Z, et al. Direct evidence of trigeminal innervation of the cochlear blood vessels. Neuroscience. 1998;84(2):559–67.CrossRefPubMed
32.
go back to reference von Brevern M, et al. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(Pt 2):365–74. von Brevern M, et al. Acute migrainous vertigo: clinical and oculographic findings. Brain. 2005;128(Pt 2):365–74.
35.
go back to reference Marano E, et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache. 2005;45(4):325–31.CrossRefPubMed Marano E, et al. Trigeminal stimulation elicits a peripheral vestibular imbalance in migraine patients. Headache. 2005;45(4):325–31.CrossRefPubMed
36.
go back to reference Shin JH, et al. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58–67.CrossRefPubMed Shin JH, et al. Altered brain metabolism in vestibular migraine: comparison of interictal and ictal findings. Cephalalgia. 2014;34(1):58–67.CrossRefPubMed
37.
go back to reference Russo A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120–6.CrossRefPubMed Russo A, et al. Abnormal thalamic function in patients with vestibular migraine. Neurology. 2014;82(23):2120–6.CrossRefPubMed
39.
go back to reference •• Cassano D, Pizza V, Busillo V. P074. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain. 2015;16(Suppl 1):A114. This article is one of few studies for acute treatment of vestibular migraine.CrossRefPubMedPubMedCentral •• Cassano D, Pizza V, Busillo V. P074. Almotriptan in the acute treatment of vestibular migraine: a retrospective study. J Headache Pain. 2015;16(Suppl 1):A114. This article is one of few studies for acute treatment of vestibular migraine.CrossRefPubMedPubMedCentral
40.
go back to reference •• Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006;116(10):1782–6. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed •• Maione A. Migraine-related vertigo: diagnostic criteria and prophylactic treatment. Laryngoscope. 2006;116(10):1782–6. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
41.
go back to reference •• Neuhauser H, et al. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60(5):882–3. This article is one of few studies for acute treatment of vestibular migraine.CrossRefPubMed •• Neuhauser H, et al. Zolmitriptan for treatment of migrainous vertigo: a pilot randomized placebo-controlled trial. Neurology. 2003;60(5):882–3. This article is one of few studies for acute treatment of vestibular migraine.CrossRefPubMed
42.
go back to reference Celebisoy N, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016;273(10):2947–51.CrossRefPubMed Celebisoy N, et al. Acetazolamide in vestibular migraine prophylaxis: a retrospective study. Eur Arch Otorhinolaryngol. 2016;273(10):2947–51.CrossRefPubMed
43.
go back to reference • Salmito MC, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol. 2017;83(4):404-10. This article is one of few studies for the preventive treatment of vestibular migraine. • Salmito MC, et al. Prophylactic treatment of vestibular migraine. Braz J Otorhinolaryngol. 2017;83(4):404-10. This article is one of few studies for the preventive treatment of vestibular migraine.
44.
go back to reference •• Taghdiri F, et al. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Spring. 2014;3:231. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRef •• Taghdiri F, et al. Cinnarizine for the prophylaxis of migraine associated vertigo: a retrospective study. Spring. 2014;3:231. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRef
45.
go back to reference •• Teggi R, et al. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci. 2015;36(10):1869–73. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRefPubMed •• Teggi R, et al. Fixed combination of cinnarizine and dimenhydrinate in the prophylactic therapy of vestibular migraine: an observational study. Neurol Sci. 2015;36(10):1869–73. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRefPubMed
46.
go back to reference Teive HA, et al. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord. 2004;10(4):243–5.CrossRefPubMed Teive HA, et al. Flunarizine and cinnarizine-induced parkinsonism: a historical and clinical analysis. Parkinsonism Relat Disord. 2004;10(4):243–5.CrossRefPubMed
47.
go back to reference • Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004;2:103–8. This article is one of few studies for the preventive treatment of vestibular migraine. • Bisdorff AR. Treatment of migraine related vertigo with lamotrigine an observational study. Bull Soc Sci Med Grand Duche Luxemb. 2004;2:103–8. This article is one of few studies for the preventive treatment of vestibular migraine.
48.
go back to reference • Waterston J. Chronic migrainous vertigo. J Clin Neurosci. 2004;11(4):384–8. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed • Waterston J. Chronic migrainous vertigo. J Clin Neurosci. 2004;11(4):384–8. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
49.
go back to reference Morganti LO, et al. Vestibular migraine: clinical and epidemiological aspects. Braz J Otorhinolaryngol. 2016;82(4):397–402.CrossRefPubMed Morganti LO, et al. Vestibular migraine: clinical and epidemiological aspects. Braz J Otorhinolaryngol. 2016;82(4):397–402.CrossRefPubMed
50.
go back to reference •• Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain. 2011;12(1):81–8. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed •• Furman JM, Marcus DA, Balaban CD. Rizatriptan reduces vestibular-induced motion sickness in migraineurs. J Headache Pain. 2011;12(1):81–8. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
51.
go back to reference •• Gode S, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed •• Gode S, et al. Clinical assessment of topiramate therapy in patients with migrainous vertigo. Headache. 2010;50(1):77–84. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
52.
go back to reference • Carmona S, Settecase N. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann N Y Acad Sci. 2005;1039:517–20. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed • Carmona S, Settecase N. Use of topiramate (topamax) in a subgroup of migraine-vertigo patients with auditory symptoms. Ann N Y Acad Sci. 2005;1039:517–20. This article is one of few stuides for the preventive treatment of vestibular migraine.CrossRefPubMed
53.
go back to reference • Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18(3):350–4. This article is one of few studies for acute treament of vestibular migraine.PubMed • Bikhazi P, Jackson C, Ruckenstein MJ. Efficacy of antimigrainous therapy in the treatment of migraine-associated dizziness. Am J Otol. 1997;18(3):350–4. This article is one of few studies for acute treament of vestibular migraine.PubMed
54.
go back to reference Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973–89. Silberstein SD. Preventive migraine treatment. Continuum (Minneap Minn). 2015;21(4 Headache):973–89.
55.
go back to reference •• Lepcha A, et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931–6. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRefPubMed •• Lepcha A, et al. Flunarizine in the prophylaxis of migrainous vertigo: a randomized controlled trial. Eur Arch Otorhinolaryngol. 2014;271(11):2931–6. This article is one of few studies for the preventive treatment of vestibular migraine.CrossRefPubMed
56.
go back to reference Brandes JL, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965–73.CrossRefPubMed Brandes JL, et al. Topiramate for migraine prevention: a randomized controlled trial. JAMA. 2004;291(8):965–73.CrossRefPubMed
57.
go back to reference Linde M, et al. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010610. Linde M, et al. Topiramate for the prophylaxis of episodic migraine in adults. Cochrane Database Syst Rev. 2013;6:CD010610.
59.
go back to reference Dixon AK, et al. Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). Arzneimittelforschung. 1977;27(10):1968–79.PubMed Dixon AK, et al. Pharmacological properties of 4(1-methyl-4-piperidylidine)-9,10-dihydro-4H-benzo-[4,5]cyclohepta[1,2]-thiophene hydrogen maleate (pizotifen). Arzneimittelforschung. 1977;27(10):1968–79.PubMed
60.
go back to reference Vitkovic J, et al. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–48.CrossRefPubMed Vitkovic J, et al. Vestibular rehabilitation outcomes in patients with and without vestibular migraine. J Neurol. 2013;260(12):3039–48.CrossRefPubMed
64.
go back to reference Radtke A, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607–14.CrossRefPubMed Radtke A, et al. Vestibular migraine: long-term follow-up of clinical symptoms and vestibulo-cochlear findings. Neurology. 2012;79(15):1607–14.CrossRefPubMed
65.
go back to reference Lee JW, et al. Clinical manifestation and prognosis of vestibular migraine according to the vestibular function test results. Korean J Audiol. 2013;17(1):18–22.CrossRefPubMedPubMedCentral Lee JW, et al. Clinical manifestation and prognosis of vestibular migraine according to the vestibular function test results. Korean J Audiol. 2013;17(1):18–22.CrossRefPubMedPubMedCentral
Metadata
Title
Current Treatment Options: Vestibular Migraine
Authors
Clinton G. Lauritsen, DO
Michael J. Marmura, MD
Publication date
01-11-2017
Publisher
Springer US
Published in
Current Treatment Options in Neurology / Issue 11/2017
Print ISSN: 1092-8480
Electronic ISSN: 1534-3138
DOI
https://doi.org/10.1007/s11940-017-0476-z

Other articles of this Issue 11/2017

Current Treatment Options in Neurology 11/2017 Go to the issue

Neuromuscular Disorders (C Fournier, Section Editor)

Treatment Opportunities in Patients With Metabolic Myopathies

Critical Care Neurology (K Sheth, Section Editor)

Resumption of Anticoagulation After Intracranial Hemorrhage

Neurologic Ophthalmology and Otology (RK Shin and DR Gold, Section Editors)

Treatment of Blepharospasm/Hemifacial Spasm